Single User License
INR 16873
Site License
INR 33745
Corporate User License
INR 50618

Service Tax Additional

select a format
Price

Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Fluidigm Corporation (FLDM)-Medical Equipment-Deals and Alliances Profile

Fluidigm Corporation (FLDM)-Medical Equipment-Deals and Alliances Profile


  Request for Sample Report

Executive Summary

Summary

Fluidigm Corporation (Fluidigm) formerly Mycometrix Corporation is a biotechnology company that manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company's products systems include biomark HD system, access array system, C1 system, callisto system, EP1 system, polaris system, juno system, and helios. It provides custom assays such as SNP type assays, maxplar antibodies, delta gene assays and access array assays. Fluidigm offers software, which include fluidigm cytobank analysis, singular analysis toolset, SNP genotyping analysis, real-time PCR analysis, and digital PCR analysis. The company's C1 system supports mRNA sequencing, DNA sequencing, miRNA analysis and additional applications through the C1 open app IFC. It has presence in the US and India. Fluidigm is headquartered in South San Francisco, California, the US.

Fluidigm Corporation (FLDM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Fluidigm Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6

Fluidigm Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 7

Fluidigm Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8

Fluidigm Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 9

Fluidigm Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 10

Fluidigm Corporation, Medical Equipment, Deal Details 11

Venture Financing 11

DVS Sciences Secures USD 14.6 Million In Series A Venture Financing 11

Partnerships 13

OpGen Enters into Co-Development Agreement with Fluidigm 13

Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 14

Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 16

Equity Offering 17

Fluidigm Completes Public Offering Of Common Stock For USD 60 Million 17

Fluidigm Completes Underwriters Over-Allotment Of USD 86 Million 19

Fluidigm Completes IPO Of Common Stock For USD 86.3 Million 21

Debt Offering 23

Fluidigm Completes Public Offering Of Notes Due 2034 For USD 201.3 Million 23

Acquisition 25

Fluidigm Completes Acquisition Of DVS Sciences For USD 207.5 Million 25

Fluidigm Corporation-Key Competitors 28

Key Employees 29

Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Strategy And Business Planning 31

Sep 03, 2015: Australia's First Single-Cell Genomics Centre of Excellence Opens at Monash Health Translation Precinct 31

Feb 05, 2015: Science for Life Laboratory Forms Swedish National Center for Single-Cell Biology 33

Financial Announcements 34

Aug 04, 2016: Fluidigm Announces Q2 2016 Financial Results 34

May 05, 2016: Fluidigm Announces First Quarter Financial Results 36

Feb 04, 2016: Fluidigm Announces Q4-Full Year 2015 Financial Results 38

Oct 29, 2015: Fluidigm Reports Q3 2015 Financial Results 39

Aug 06, 2015: Fluidigm Reports Q2 2015 Financial Results 41

May 07, 2015: Fluidigm Reports Q1 2015 Financial Results 43

Feb 05, 2015: Fluidigm Reports Q4 and Full Year 2014 Financial Results 44

Jan 13, 2015: Fluidigm Announces Preliminary Fourth Quarter 2014 Revenue and Issues 2015 Revenue Guidance 46

Corporate Communications 47

Aug 04, 2016: Fluidigm Appoints New President and Chief Operating Officer 47

May 07, 2015: Fluidigm Appoints Steve McPhail General Manager of Production Genomics Business 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Figures

Fluidigm Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 1

Fluidigm Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 1

Fluidigm Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 1

Fluidigm Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 1

Fluidigm Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6

Fluidigm Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 7

Fluidigm Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8

Fluidigm Corporation, Medical Equipment, Deals by Market, 2010 to YTD 2016 9

List of Tables

Fluidigm Corporation, Medical Equipment, Key Facts, 2015 1

Fluidigm Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 1

Fluidigm Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6

Fluidigm Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 7

Fluidigm Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8

Fluidigm Corporation, Deals By Market, 2010 to YTD 2016 9

Fluidigm Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 10

DVS Sciences Secures USD 14.6 Million In Series A Venture Financing 11

OpGen Enters into Co-Development Agreement with Fluidigm 13

Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 14

Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 16

Fluidigm Completes Public Offering Of Common Stock For USD 60 Million 17

Fluidigm Completes Underwriters Over-Allotment Of USD 86 Million 19

Fluidigm Completes IPO Of Common Stock For USD 86.3 Million 21

Fluidigm Completes Public Offering Of Notes Due 2034 For USD 201.3 Million 23

Fluidigm Completes Acquisition Of DVS Sciences For USD 207.5 Million 25

Fluidigm Corporation, Key Competitors 28

Fluidigm Corporation, Key Employees 29

Fluidigm Corporation, Other Locations 30

Fluidigm Corporation, Subsidiaries 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Fluidigm Corporation, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com